Clinical Trials · NCT04426474
A Study of LY3502970 in Participants With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 68
- Start date
- Oct 2020
- Locations
- 6 sites, United States, Germany
- Primary endpoint
- Number of Participants With One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug